Independent Board Members Resign from 23andMe Amidst Tensions with CEO
The resignation of all independent board members at 23andMe represents a significant shift for the genetic-testing company, following months of unresolved conversations with CEO Anne Wojcicki.
Wojcicki's ambition to privatize the company and retain personal control became a contentious issue, with the board expressing dissatisfaction with the proposals presented.